The FDA doesn't publish a pen testing checklist, but its guidance, 524B requirements, and reviewer expectations add up to one. Here's what medical device makers must cover before, during, and after the test.

Standard pen test scoping frameworks weren't built for pharma. Learn how to scope an engagement that covers validated systems under 21 CFR Part 11 and protects high-value formulation and clinical data from targeted threats.

Section 524B made medical device cybersecurity a legal requirement, not a guideline. Learn what the FDA expects from your pen test scope, evidence package, and postmarket vulnerability management process.

Annual penetration testing produces documentation, not security. Learn how Penetration Testing as a Service fits manufacturing's high-change OT environments and closes the gap between discovery and fix.

Don't wait for an auditor to tell you what you missed. Learn how to build an OT attack surface map using passive discovery, zone mapping, and risk-based prioritization before your next security audit.